Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review
European Journal of Neurology2023Vol. 31(3), pp. e16157–e16157
Citations Over TimeTop 10% of 2023 papers
Valery L. Feigin, Sheila Cristina Ouriques Martins, Michael Brainin, Bo Norrving, Saltanat Kamenova, Azhar Giniyat, Аida Kondybayeva, Daulet Aldyngurov, Magripa Bapayeva, Murat Zhanuzakov, Graeme J. Hankey
Abstract
Primary stroke and CVD prevention needs to be done in all individuals with increased risk of CVD/stroke. Pharmacological management of blood pressure and blood cholesterol should not be solely based on the high CVD risk treatment thresholds. International guidelines and global strategies for primary CVD/stroke prevention need to be revised.
Related Papers
- → Randomized Controlled Drug Trials on Very Elderly Subjects: Descriptive and Methodological Analysis of Trials Published Between 1990 and 2002 and Comparison With Trials on Adults(2005)36 cited
- → Practice and Educational Effects of a Simulated Randomized Controlled Trial for Acupuncture School Teachers(2010)
- → Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative Medicine(2004)
- A compatision between one visit RCT and several visit RCT for cracked teeth.(2007)
- Basical Clinical Observation of Cracked Tooth with One visit RCT(2003)